Skip to content
Search

Latest Stories

Pharmacist support vital to help smokers stub it out for good, new study suggests

While a tenth of Brits have started smoking or re-started smoking because of the pandemic, a fifth of quitters rely on their local pharmacists for advice, a new research has shown.

The revelation comes after a recent University College London (UCL) study showed an increase in quitting rates.


The latest data gathered by a mobile app suggests the UCL study is “just one side of the story”.

Behavioural scientist and founder of the Smoke Free app, Dr David Crane, explains: “There is good evidence that Covid-19 is motivating some people to quit, but the data we’ve gathered indicates that it’s having the opposite effect on others. For them, Covid-19 has actually increased their desire to smoke.”

He thinks although it "might seem counterintuitive at first" people want to start smoking now because it's "a very unsettling and upsetting time for many".

"For smokers, that’s smoking. We, and I say this as an ex-smoker, think smoking makes us feel better. It doesn’t really of course, in fact people usually say they’re happier after they’ve quit. But believing smoking increases pleasure or reduces pain might explain why some people are smoking more now.”

The study has found that a further 10 per cent of the smokers who were going to quit decided not to once the pandemic hit.

A third of smokers admitted to smoking through the pandemic, despite knowing it is likely to make them more susceptible to serious complications should they contract Covid-19.

Another 10 per cent said that working from home during lockdown has enabled them to smoke more than when they were going to their usual place of work.

Stopping smoking isn’t easy: ASH

Deborah Arnott, chief executive of health charity Action on Smoking & Health (ASH), concurs with Dr Crane and says that this finding “doesn’t contradict the UCL study.”

“While at population level more smokers are quitting than before and quitting more successfully, not all smokers are quitting – some are not, some are smoking more, and some having quit have relapsed back to smoking,” she explains.

“Stopping smoking isn’t easy and the more help and support smokers get the more likely they are to succeed.”

As well as smoking uptake increasing, thirty-four percent of Brits admit to sleeping less since the pandemic started, 25 per cent are exercising less, 20 per cent are eating more unhealthily and 16 per cent are drinking more than before.

A staggering 40 per cent of Brits admit to worrying more in general this year.

Of the smokers who have tried to quit before, 40 per cent have done it on their own, whilst only 18 per cent have used NHS services in the past. Around 16 per cent of smokers questioned through Smoke Free’s research, said they would go to the pharmacy as their first port of call for stop smoking advice.

Dr David Crane continues: “Help people stop smoking and we reduce demand on the NHS both now and in the future. We free doctors and beds and allow money to be spent on other diseases.

"Even with a pandemic, smoking remains the number one cause of preventable illness and death worldwide. People need help to quit and apps bring this help to large numbers at low cost and with great benefit.”

The Smoke Free app, which offers 24/7 access to stop smoking advisors, has been downloaded five million times after two randomised control trials with over 90,000 participants have proven that the app doubles quit rates.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less